Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2

J Travel Med. 2021 Jun 1;28(4):taab051. doi: 10.1093/jtm/taab051.
No abstract available

Keywords: N501Y; SARS-CoV-2; escape mutants, vaccine efficacy; neutralization; variant of concern.

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / immunology*
  • Humans
  • SARS-CoV-2*
  • Vaccines, Inactivated / immunology

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19 Vaccines
  • Vaccines, Inactivated

Supplementary concepts

  • SARS-CoV-2 variants